United States
Germany
Japan
United Kingdom
China
Anti-TNFRSF5 / CD40 Reference Antibody (ravagalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Antibodies
Anti-TNFRSF5 / CD40 Reference Antibody (sotigalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (lucatumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-TNFRSF5 / CD40 Reference Antibody (giloralimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-TNFRSF5 / CD40 Reference Antibody (mitazalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (bleselumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (dacetuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-TNFRSF5 / CD40 Reference Antibody (Emory U. anti-CD40)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-TNFRSF5 / CD40 Reference Anticody (Teneliximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-TNFRSF5 / CD40 Reference Antibody (Cifurtilimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
